Variable Outcomes of Hepatitis E Infections in Patients with Hemato-Oncologic Diseases
Oncology Research and Treatment · 2023
DOI: 10.1159/000531538 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research and Treatment, 2023. Verfasst von Viktoria Ingwersen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Oncology and Tumor Immunology (Campus Benjamin Franklin), Charité - Universitätsmedizin Berlin, corporate member of Freie U…. Hauptthemen laut MEDLINE: Hepatitis E, Hepatitis E virus, Liver Failure. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Introduction
The hepatitis E virus (HEV) represents an important cause of viral hepatitis and could cause chronic infections in immunocompromised patients. However, data about immunocompromised patients other than solid organ transplant recipients are limited.
Methods
We identified patients from a laboratory database and retrospectively compiled and analyzed clinical as well as laboratory data in detail.
Results
Overall, 22 severely immunosuppressed patients, excluding solid organ transplant recipients, were identified. Four patients did not experience viral clearance (one without and three despite ribavirin therapy). Three patients acquired the infection after allogeneic hematopoietic stem cell transplantation (alloHSCT) and recovered spontaneously, whereas another patient, infected prior to alloHSCT, developed a chronic infection. Four patients failed to clear HEV, resulting in fatal liver failure in 2 patients. The CD4+ cell counts increased in all but 1 patient attaining a sustained virological response (SVR), as compared to patients with clinical failure. Severe immunoglobulin deficiency did not appear to obviate the control of HEV. Six of ten (60%) patients with and nine of 12 (75%) patients without ribavirin therapy achieved an SVR.
Conclusions
Upfront ribavirin therapy does not appear mandatory in patients without CD4+ lymphopenia, but a prolonged HEV replication carries the risk of liver failure. Our data suggest that chronic HEV infections could cause T-cell exhaustion, which might be overruled with ribavirin therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Oncology and Tumor Immunology (Campus Benjamin Franklin), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Department of Virology, Labor Berlin, Charité-Vivantes GmbH, and Institute of Virology, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charité, Berlin, Germany.
- Department of Gastroenterology, Infectious Diseases, and Rheumatology (Campus Benjamin Franklin), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Be…
- Department of Hematology, Oncology and Tumor Immunology (Campus Mitte), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Department of Hematology, Oncology and Tumor Immunology (Campus Virchow-Klinikum), Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Zitieren
APA
Ingwersen, V., Hofmann, J., Muche, M., Le Coutre, P., Schneider, T., Leng, C., Burmeister, T., Maschmeyer, G., Keller, U., & Schwartz, S. (2023). Variable Outcomes of Hepatitis E Infections in Patients with Hemato-Oncologic Diseases. Oncology Research and Treatment. https://doi.org/10.1159/000531538
Vancouver
Ingwersen V, Hofmann J, Muche M, Le Coutre P, Schneider T, Leng C, et al. Variable Outcomes of Hepatitis E Infections in Patients with Hemato-Oncologic Diseases. Oncology Research and Treatment. 2023. doi:10.1159/000531538
BibTeX
@article{Ingwersen2023,
author = {Ingwersen, Viktoria and Hofmann, Jörg and Muche, Marion and Le Coutre, Philipp and Schneider, Thomas and Leng, Corinna and Burmeister, Thomas and Maschmeyer, Georg and Keller, Ulrich and Schwartz, Stefan},
title = {Variable Outcomes of Hepatitis E Infections in Patients with Hemato-Oncologic Diseases},
journal = {Oncology Research and Treatment},
year = {2023},
doi = {10.1159/000531538}
}
EUVIMED